Results 261 to 270 of about 870,100 (377)
ABSTRACT Objective Aortic stenosis (AS) may complicate cardiogenic shock (CS) or acute decompensated heart failure (ADHF) in a small but significant number of patients. In such cases, urgent treatment is necessary to prevent mortality and adverse outcomes.
Kyriakos Dimitriadis +9 more
wiley +1 more source
Prevalence and Prognostic Significance of Malnutrition Risk in Patients With Valvular Heart Disease. [PDF]
Li Z +15 more
europepmc +1 more source
ABSTRACT An 84‐year‐old man with multiple comorbidities including severe aortic stenosis, heart failure with a reduced ejection fraction, severe peripheral artery disease with prior bilateral iliac artery stents, and trifascicular block presented for evaluation for aortic valve replacement.
Charlene L. Rohm +4 more
wiley +1 more source
Global, regional, and national burden of non-rheumatic valvular heart disease and Its projections to 2035: comprehensive analysis of the global burden of disease study 2019. [PDF]
Ying T, Nie Q, Yan W, Wang H, Wu J.
europepmc +1 more source
896 Restrictive valvular heart disease in patients with Parkinson's disease treated with pergolide [PDF]
G VANCAMP +6 more
openalex +1 more source
ABSTRACT Aortic regurgitation (AR) develops in up to 25%−30% of patients with left ventricular assist device (LVAD). Treatment remains challenging since surgery confers significant peri‐operative risk and the lack of valvular calcification renders transfemoral transcatheter aortic valve implantation (TF‐TAVI) with non‐dedicated devices technically ...
Daniel Tai‐Leung Chan +9 more
wiley +1 more source
Prognostic implication of right ventricular-pulmonary artery coupling in valvular heart disease. [PDF]
Wu Z +7 more
europepmc +1 more source
Applying DanGer Shock Eligibility Criteria to a Real‐World Cohort of Cardiogenic Shock Patients
ABSTRACT Background The DanGer Shock trial investigated the effects of adding a microaxial flow pump to guideline‐recommended therapy in patients with ST‐elevation myocardial infarction (STEMI)‐related cardiogenic shock (CS), finding a lower all‐cause mortality at 180 days in the intervention group.
Raffaela Miriam Planka +14 more
wiley +1 more source

